Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Spinocerebellar Degenerations × regorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Carcinoma 2 Adenocarcinoma 2 Spinocerebellar Degenerations 1 HER2-positive Colorectal Cancer 1 Gastrointestinal Stromal Tumors 1 Colorectal Cancer Liver Metastases 1 Carcinoma, Hepatocellular 1 Advanced Colorectal Cancer 1

Interventions

trifluridine tipiracil drug combination 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05328908 2025-08-13

RELATIVITY-123

Bristol-Myers Squibb

Phase 3 Terminated

Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡